Drug use in business bathrooms: An exploratory study of manager encounters in New York City.
Drug use in business bathrooms: An exploratory study of manager encounters in New York City.
复制标题
商务浴室中的药物使用：对纽约市经理遭遇的探索性研究。
DOI：
10.1016/j.drugpo.2016.08.014
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Curtis,Ric
中科院分区：
文献类型：
--
作者：
Wolfson-Stofko,Brett;Bennett,AlexS;Elliott,Luther;Curtis,Ric
背景虽然公共浴室毒品注射是从注射毒品者的角度记录的，但没有研究探讨监督其营业浴室并对吸毒做出反应的业务经理的经验。默认情况下，这些管理者是药物过量事件的第一反应者，因此在美国当前阿片类药物相关过量用药流行期间具有内在利益。这项探索性研究有助于阐明纽约市企业经理与注射吸毒者、他们的用具和过量用药的经历。方法设计了一种调查工具来收集经理在其营业浴室内吸毒的情况的数据。招聘以便利和有目的的方法为指导。结果超过一半的受访经理 (58%，n= 50/86) 在他们的商务浴室中遇到过吸毒情况，超过三分之一 (34%) 的经理还发现了注射器，绝大多数 (90%) 的经理没有接受过药物过量识别或纳洛酮培训。七名经理遇到了需要紧急援助的反应迟钝的个人。结论这项研究的结果强调需要对社区利益相关者在公共注射方面的经验以及企业经理的教育外展工作进行更多研究。这项研究还表明，有必要就潜在的干预措施进行全国对话，包括扩大用药过量识别和纳洛酮培训以及监督注射设施（SIF）/毒品消费室（DCR），这可以减少公共注射及其相关的健康风险。
BackgroundThough public bathroom drug injection has been documented from the perspective of people who inject drugs, no research has explored the experiences of the business managers who oversee their business bathrooms and respond to drug use. These managers, by default, are first-responders in the event of a drug overdose and thus of intrinsic interest during the current epidemic of opioid-related overdoses in the United States. This exploratory study assists in elucidating the experiences that New York City business managers have with people who inject drugs, their paraphernalia, and their overdoses.MethodsA survey instrument was designed to collect data on manager encounters with drug use occurring in their business bathrooms. Recruitment was guided by convenience and purposive approaches.ResultsMore than half of managers interviewed (58%,n= 50/86) encountered drug use in their business bathrooms, more than a third (34%) of these managers also found syringes, and the vast majority (90%) of managers had received no overdose recognition or naloxone training. Seven managers encountered unresponsive individuals who required emergency assistance.ConclusionThe results from this study underscore the need for additional research on the experiences that community stakeholders have with public injection as well as educational outreach efforts among business managers. This research also suggests that there is need for a national dialogue about potential interventions, including expanded overdose recognition and naloxone training and supervised injection facilities (SIF)/drug consumption rooms (DCR), that could reduce public injection and its associated health risks.